BlueWind Medical today announced two-year results from a study of its Revi implantable tibial neuromodulation (iTNM) system.
A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal muscle atrophy (SMA), an inherited neuromuscular disease.
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- A new spinal cord implant may help people with spinal muscular atrophy (SMA) ...
Request To Download Free Sample of This Strategic Report @ Driving Forces Behind Growth: The exponential growth of the North America medical implant market is propelled by several key drivers.
Request To Download Free Sample of This Strategic Report @ Driving Forces of Growth: The unprecedented growth of the medical implant market is propelled by several key factors. Firstly, the aging ...
Cortigent, Inc. (CRTG) expects to raise $15 million in an initial public offering (IPO) on Friday, February 14th, IPO Scoop reports. The company will be issuing 1,500,000 shares at $10.00 per share.
Abbott announced new four-year data showing the long-term and sustained relief that its proprietary BurstDR™ spinal cord stimulation (SCS) technology provides people with chronic pain, particularly ...
Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...
Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, is proud to announce the expansion of MR labeling for its Freedom® Peripheral Nerve ...
Neurostimulation provides a relatively novel mechanism for promoting tear production through activation of the underlying nerve pathways via mechanical, chemical, or electrical stimuli.
IoT devices have become indispensable in modern healthcare, enabling a highly interconnected ecosystem that facilitates ...
A live Q&A session with White will follow the presentation. Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.